190 related articles for article (PubMed ID: 28983651)
1. [Cytoreductive, radical prostatectomy in metastatic prostate cancer].
Chaloupka M; Herlemann A; Spek A; Gratzke C; Stief C
Urologe A; 2017 Nov; 56(11):1430-1434. PubMed ID: 28983651
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
Mathieu R; Korn SM; Bensalah K; Kramer G; Shariat SF
World J Urol; 2017 Apr; 35(4):567-577. PubMed ID: 27502935
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.
Becker JA; Berg KD; Røder MA; Brasso K; Iversen P
Scand J Urol; 2018 Feb; 52(1):1-7. PubMed ID: 28818014
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
5. Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.
Steuber T; Berg KD; Røder MA; Brasso K; Iversen P; Huland H; Tiebel A; Schlomm T; Haese A; Salomon G; Budäus L; Tilki D; Heinzer H; Graefen M; Mandel P
Eur Urol Focus; 2017 Dec; 3(6):646-649. PubMed ID: 28753877
[TBL] [Abstract][Full Text] [Related]
6. Words of wisdom. Re: Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases--results of a feasibility and case-control study.
Satkunasivam R; Aron M
Eur Urol; 2015 Mar; 67(3):589-90. PubMed ID: 25760411
[No Abstract] [Full Text] [Related]
7. Re: Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study: A. Heidenreich, D. Pfister and D. Porres J Urol 2015;193:832-838.
Aydemir H; Kumsar Ş
J Urol; 2015 Sep; 194(3):853-4; discussion 854-5. PubMed ID: 26048857
[No Abstract] [Full Text] [Related]
8. [Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis].
Spek A; Herlemann A; Gratzke C; Stief CG
Urologe A; 2017 May; 56(5):595-598. PubMed ID: 28314969
[TBL] [Abstract][Full Text] [Related]
9. Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes.
Costa WH; Guimarães GC
Int Braz J Urol; 2016; 42(5):876-879. PubMed ID: 27716456
[No Abstract] [Full Text] [Related]
10. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Heidenreich A; Pfister D
Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
[TBL] [Abstract][Full Text] [Related]
11. Role of radical prostatectomy in metastatic prostate cancer: A review.
Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective Local Treatment of Metastatic Prostate Cancer (LoMP) Trial.
Poelaert F; Verbaeys C; Rappe B; Kimpe B; Billiet I; Plancke H; Decaestecker K; Fonteyne V; Buelens S; Lumen N
Urology; 2017 Aug; 106():146-152. PubMed ID: 28435034
[TBL] [Abstract][Full Text] [Related]
13. [Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study].
Heidenreich A; Pfister D; Brehmer B; Porres D
Urologe A; 2015 Jan; 54(1):14-21. PubMed ID: 25519996
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer.
Preisser F; Mazzone E; Nazzani S; Bandini M; Tian Z; Marchioni M; Steuber T; Saad F; Montorsi F; Shariat SF; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol; 2018 Dec; 74(6):693-696. PubMed ID: 30037529
[TBL] [Abstract][Full Text] [Related]
15. The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer.
Ristau BT; Cahn D; Uzzo RG; Chapin BF; Smaldone MC
Future Oncol; 2016 Mar; 12(5):687-99. PubMed ID: 26839141
[TBL] [Abstract][Full Text] [Related]
16. [Radical cancer surgery of renal cell and prostate carcinoma with hematogenous metastasis: benefits].
Heidenreich A; Pfister D; Porres D
Urologe A; 2014 Jun; 53(6):823-31. PubMed ID: 24824471
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive and Palliative Radical Prostatectomy, Extended Lymphadenectomy and Bilateral Orchiectomy in Advanced Prostate Cancer with Oligo and Widespread Bone Metastases: Result of a Feasibility, Our Initial Experience.
Simforoosh N; Dadpour M; Mofid B
Urol J; 2019 May; 16(2):162-167. PubMed ID: 30393838
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive prostatectomy: what is the evidence? A systematic review.
Albisinni S; Aoun F; Diamand R; Al-Hajj Obeid W; Porpiglia F; Roumeguère T; De Nunzio C
Minerva Urol Nefrol; 2019 Feb; 71(1):1-8. PubMed ID: 30547907
[TBL] [Abstract][Full Text] [Related]
19. Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No.
Ristau BT; Smaldone MC
Int Braz J Urol; 2016; 42(5):880-882. PubMed ID: 27716457
[No Abstract] [Full Text] [Related]
20. Radical prostatectomy for locally advanced and metastatic prostate cancer.
Veeratterapillay R; Goonewardene SS; Barclay J; Persad R; Bach C
Ann R Coll Surg Engl; 2017 Apr; 99(4):259-264. PubMed ID: 28349755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
